We are live on ! Find out more
TIL icon

Instil Bio
TIL

98 hedge funds and large institutions have $551M invested in Instil Bio in 2022 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 32 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

314% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 7

68% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 19

26% more funds holding

Funds holding: 78 → 98 (+20)

0.04% more ownership

Funds ownership: 4.57% → 4.61% (+0.04%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

57% less capital invested

Capital invested by funds: $1.27B → $551M (-$717M)

Holders
98
Holders Change
+20
Holders Change %
+25.64%
% of All Funds
1.65%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
29
Increased
32
Reduced
19
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$19.8M
2
ACH
ArrowMark Colorado Holdings
Colorado
+$8.93M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.87M
4
BlackRock
BlackRock
New York
+$5.94M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.51M

Top Sellers

Rank Fund Capital Flow
1
HA
HHLR Advisors
Cayman Islands
-$25.6M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$21M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$9.28M
4
VA
VR Adviser
New York
-$6.14M
5
NIP
Nicholas Investment Partners
California
-$2.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
Stifel Financial
76
Stifel Financial
Missouri
$53K – – –
SSA
77
Schonfeld Strategic Advisors
New York
$53K +$82.1K +580 New
AB
78
Amalgamated Bank
New York
$41K +$8.92K +63 +17%
DekaBank Deutsche Girozentrale
79
DekaBank Deutsche Girozentrale
Germany
$40K – – –
TRCT
80
Tower Research Capital (TRC)
New York
$34K +$44.3K +313 +559%
Citigroup
81
Citigroup
New York
$32K +$14K +99 +40%
Legal & General Group
82
Legal & General Group
United Kingdom
$27K +$850 +6 +2%
ACM
83
ACT Capital Management
Pennsylvania
$23K -$35.4K -250 -50%
AIP
84
Ameritas Investment Partners
Nebraska
$19K – – –
MLICM
85
Metropolitan Life Insurance Company (MetLife)
New York
$17.6K – – –
Barclays
86
Barclays
United Kingdom
$16K -$37.4K -264 -60%
LC
87
Lindbrook Capital
California
$6K – – –
QT
88
Quantbot Technologies
New York
$3K +$4.96K +35 New
Royal Bank of Canada
89
Royal Bank of Canada
Ontario, Canada
$2K -$20.7K -146 -88%
Daiwa Securities Group
90
Daiwa Securities Group
Japan
$2K – – –
SOW
91
State of Wyoming
Wyoming
$2K +$567 +4 +31%
PHK
92
Point72 Hong Kong
Hong Kong
$2K +$3.26K +23 New
Wells Fargo
93
Wells Fargo
California
$2K +$3.82K +27 New
QCG
94
Quadrant Capital Group
Ohio
$1K -$190K -1,340 -100%
Osaic Holdings
95
Osaic Holdings
Arizona
$1K – – –
HA
96
HHLR Advisors
Cayman Islands
– -$25.6M -119,273 Closed
Wellington Management Group
97
Wellington Management Group
Massachusetts
– -$9.28M -43,146 Closed
State of Wisconsin Investment Board
98
State of Wisconsin Investment Board
Wisconsin
– -$768K -3,570 Closed
Los Angeles Capital Management
99
Los Angeles Capital Management
California
– -$456K -2,123 Closed
CF
100
CNA Financial
Illinois
– -$244K -1,134 Closed
1 2 3
4
5

TIL Hedge Fund Activity: Q2 2022 in Review

98 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q2 2022, worth a combined $551M — down 57% from $1.27B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new TIL positions and 7 closed out — a net gain of 22 holders — while 32 added to existing stakes and 19 trimmed.

The largest buyer was RA Capital Management, adding an estimated $19.8M. The largest seller was HHLR Advisors, exiting entirely with an estimated $25.6M sold.

  • 98 institutional investors held Instil Bio (TIL) as of Q2 2022, up from 78 in Q1 2022.
  • Funds reported $551M of Instil Bio stock for Q2 2022, down 57% quarter-over-quarter.
  • 29 funds opened new Instil Bio positions in Q2 2022 and 7 closed out, a net change of +22 holders.
  • The largest Instil Bio buyer in Q2 2022 was RA Capital Management, an estimated $19.8M added.
  • The largest Instil Bio seller in Q2 2022 was HHLR Advisors, an estimated $25.6M sold.

Based on aggregated 13F filings for Q2 2022.